- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Aspirin in Breast Cancer Survival
Authors
Keywords
Breast cancer, Aspirin, Survival, Inflammation, COX-2
Journal
Current Oncology Reports
Volume 19, Issue 7, Pages -
Publisher
Springer Nature
Online
2017-06-09
DOI
10.1007/s11912-017-0605-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients
- (2016) V. Aristarco et al. Cancer Prevention Research
- Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies
- (2016) Peter C. Elwood et al. PLoS One
- Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies
- (2015) Shanliang Zhong et al. BREAST CANCER RESEARCH AND TREATMENT
- Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis
- (2015) Xuan-zhang Huang et al. CANCER CAUSES & CONTROL
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis
- (2015) Honor J. Hugo et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen
- (2015) Samar Basu et al. PLoS One
- Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden
- (2014) Michelle D Holmes et al. BMC CANCER
- Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice
- (2014) Liam J Murray et al. BREAST CANCER RESEARCH
- Recent Prediagnostic Aspirin Use, Lymph Node Involvement, and 5-Year Mortality in Women with Stage I-III Breast Cancer: A Nationwide Population-Based Cohort Study
- (2014) T. I. Barron et al. CANCER RESEARCH
- NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin-Aromatase Interactions
- (2014) L. W. Bowers et al. CANCER RESEARCH
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
- (2014) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Analgesic Use and Patterns of Estrogen Metabolism in Premenopausal Women
- (2014) Renée T. Fortner et al. Hormones & Cancer
- Initiation of Aspirin Therapy Modulates Angiogenic Protein Levels in Women with Breast Cancer Receiving Tamoxifen Therapy
- (2013) Chris E. Holmes et al. CTS-Clinical and Translational Science
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial
- (2013) Paul E. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
- (2012) Farhat V.N. Din et al. GASTROENTEROLOGY
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Levels of COX-2 and Prostaglandin E 2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women
- (2012) Kotha Subbaramaiah et al. Cancer Discovery
- COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
- (2011) Michelle D. Holmes et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
- (2011) Patrick G. Morris et al. Cancer Prevention Research
- COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer
- (2010) Sharon A Glynn et al. BMC CANCER
- Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer
- (2010) Lesley-Ann Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- New Strategies in Colorectal Cancer: Biomarkers of Response to Epidermal Growth Factor Receptor Monoclonal Antibodies and Potential Therapeutic Targets in Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Pathways
- (2010) A. Dasari et al. CLINICAL CANCER RESEARCH
- Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors
- (2010) Karen J. Wernli et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Platelet functions beyond hemostasis
- (2009) S. S. SMYTH et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Aspirin, salicylates, and cancer
- (2009) Peter C Elwood et al. LANCET
- Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study
- (2008) C. Falandry et al. BREAST CANCER RESEARCH AND TREATMENT
- Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women
- (2008) A. G. Hudson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination With Celecoxib
- (2008) Luc Yves Dirix et al. JOURNAL OF CLINICAL ONCOLOGY
- Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer
- (2008) Louis Wing-Cheong Chow et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now